1 / 15

A NCA disease : i mmunoserology and p athogenesis

A NCA disease : i mmunoserology and p athogenesis. A lenka Vizjak Institute of Pathology · Faculty of Medicine University of Ljubljana, Ljubljana, Slovenia. Antineutrophil cytoplasmic antibodies (ANCA).

alden
Télécharger la présentation

A NCA disease : i mmunoserology and p athogenesis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ANCAdisease: immunoserology and pathogenesis Alenka Vizjak Institute of Pathology · Faculty of Medicine University of Ljubljana, Ljubljana, Slovenia

  2. Antineutrophilcytoplasmicantibodies (ANCA) • Davies DJ etal. Necrotizingglomerulonephritiswith ANCA. Med J 1982; 285:606 • Van der Woude FJetal. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:425 • Jennette JCetal. ANCA-associated GN and vasculitis. Am J Pathol1989; 135: 921 Discoveryof ANCA – ofkeyimportancefortheclassificationofsmallvesselvasculitides(in thekidneynecrotizingcrescentic GN) and understandingoftheirpathogenesis(1. immunecomplex, 2. anti-GBM, 3. ANCA)

  3. ANCA disease Pathogenetically determinedgroup of small-vessel vasculitides including: • Wegener’s granulomatosis • Microscopic polyangiitis • Pauci-immune necrotizing crescentic GN= kidney-limited microscopic poliangiitis • Churg-Strauss syndrome

  4. ANCA antigens ANCA specific for various proteins, mostlyenzymes, localized in the cytoplasmic lyzosomes of neutrophils and monocytes. Major target antigens for ANCA in patients with pauci-immune small vessel vasculitides : • Myeloperoxidase (MPO) – epitope expressed by 130 kDa native moleculein the azurophilic granules • Proteinase 3 (PR3) – 28 kDa serine proteinase, colocalized with MPO in the azurophilic granules

  5. ANCA antigens Other ANCA antigens: lactoferrin, elastase, lysozyme, cathepsin G, azurocidin, bactericidal permeability increasing protein (BPI), alpha-enolase, defensin, unknown human lysosomal-associated membrane protein 2 (h-lamp-2) - homologous to bacterial protein FimH (Kain R et al. Nat Med 2008)

  6. ANCA testing • Indirect immunofluorescence (IIF)C-ANCA ( PR3)P-ANCA, with nuclear extension ( MPO)P-ANCA, without nuclear extension ( mostly unknown antigens)Atypical C-ANCA ( PR3 after treatment orBPI, MPO, other, often multiple antigens)Atypical ANCA ( other, often multiple antigens) • Enzyme-linked immunosorbent assay (ELISA)Antigen specificity, quantitative value (relative)

  7. Sensitivity and specificity of ANCA (IIF + ELISA for PR3, MPO) from different studies in the literature Disease Sensitivity of ANCA ___________________________________________________ Limited Wegener's granulomatosis 50-66 % Generalized Wegener's granulomatosis80-98 % Microscopic polyangiitis 82-90 % Pauci-immune necrotizing extracap GN 90-95 % Churg-Strauss syndrome 60-70 % Control group Specificity of ANCA ____________________________________________________ Patients with various other diseases 76-91 % Healthy subjects 94-99 %

  8. Selected demographic features and serologic findings in 423 ANCA positive patients grouped according to their clinico-pathologic settings (Institute of Pathology, Faculty of Medicine, Ljubljana)

  9. Clinico-pathologic diagnosis in relation to ANCA antigen specificity in 423 ANCA positive patients (Institute of Pathology, Faculty of Medicine, Ljubljana)

  10. Patogenetic role of ANCA • Clinical evidenceCorrelation between ANCA values and activity of vasculitis, as well as relapsesDrug-induced ANCA vasculitis • In vitro studiesActivation of neutrophils by binding of ANCAs  release of destructive enzymes and toxic reactive oxygen radicals, as well as neutrophil extracellular traps;factors released by activated neutrophils activate the alternative complement pathway;ANCAs bind also to ANCA antigens adsorbed to anionic endothelium and GBM, enhancing complement dependent cytotoxicity; ANCAs disregulate neutrophil apoptosis  necrosis; specific T lymphocytes for PR3 • Several animal models of ANCA diseaseMPO-ANCA, PR3-ANCA, anti-LAMP-2 antibodies

  11. Falk RJ, Jennette JC. J Am Soc Nephrol 2010, 21: 745-752

  12. De Lind van Wijngaarden RAF et al, Clin JASN, 2008, 3: 237-252

  13. Conclusions • PR3- and MPO-ANCA are highly specific diagnostic marker for pauci-immune small vessel vasculitides determined as ANCA disease. Rarely, ANCA specific for other antigens are involved in ANCA disease. • ANCA can be not rarely positive in various other diseases, mostly with an atypical IIF pattern, in low values,and specificities for rare and unknown ANCA antigens. • In view of clinical serologic correlations, as well as in vitrostudies and in vivoanimal models ANCA evidently have a key role in the pathogenesis of glomerular and vascular lesions in ANCAdisease.

More Related